Women’s health: contraception and termination of pregnancy (Webinar)

Outline:

Exercising reproductive choices is a key determinant of women’s reproductive and general health. This includes access and information on modern contraceptives, emergency contraception as well as medical or surgical termination of pregnancy. As medication experts, pharmacists play an important role in empowering women to effectively exercise their reproductive choices by providing them with evidence-based advice and timely referrals.

Speaker:

Dr Safeera Hussainy is a registered pharmacist and Adjunct Senior Lecturer at the Dept of General Practice, School of Primary and Allied Health Care, Monash University. She has a strong passion for women’s health and is recognised as the national pharmacy expert in emergency contraception (EC). Her research is focused on defining and optimising pharmacists’ performance as key health care providers of EC. It has influenced policy and practice, twice prompting major revisions to the national pharmacy (PSA) EC clinical guideline, resulting in a measured improvement in pharmacists’ practices.

Safeera is a Chief Investigator on a recently awarded $2.5 million NHMRC Centre for Research Excellence in Women's Health (SPHERE) to commence in early 2019, where her role will be to supervise studies on women's views on pharmacy-led contraception provision, pharmacists' views on promoting and providing long acting reversible contraception (LARC) and the testing of a contraceptive decision aid in pharmacies.

Learning outcomes:

After completing this activity, pharmacists should be able to:

• Describe the role of the pharmacist and discuss the timing and quality of conversations and advice by pharmacists that can better support women sexual and reproductive health.
• Compare and contrast available methods of contraception to better assist women consider the range of factors that influence their contraceptive choice.
• Describe the role of long-acting reversible contraceptives (LARCS) including conversations around LARCS in a pharmacy setting.
• Describe the differences in the roles and efficacy of ulipristal acetate and levonorgestrel in emergency contraception and how they compare to copper IUD.
• Discuss the difference between medical and surgical termination of pregnancy and how these can be accessed and the role of the pharmacist as the provider of MS 2-Step.

Accreditation Code: CVP181103B

Group 1:   1.50 Credits 
Group 2:   3.00 Credits